- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe pain, cancer pain, severe disabling pain
- Meeting Date: July 2024
- Public Summary Document (PSD) July 2024 PBAC Meeting - (PDF 543KB)
- Public Summary Document (PSD) July 2024 PBAC Meeting - (Word 107KB)
Morphine – July 2024
Morphine; Tablet containing morphine sulfate pentahydrate 30 mg; Anamorph®
Last updated
30 May 2025